<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The thrombin clotting time (TCT) has been used at our institution, along with the activated partial thromboplastin time (aPTT), for monitoring <z:chebi fb="5" ids="28304">heparin</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>We have observed that, in some patients, a discrepancy develops between the <z:chebi fb="5" ids="28304">heparin</z:chebi> levels predicted by the TCT and the aPTT with the TCT consistently predicting a lower <z:chebi fb="5" ids="28304">heparin</z:chebi> level than the aPTT </plain></SENT>
<SENT sid="2" pm="."><plain>An inverse relationship was noted between the functional antithrombin III (AT-III) level and the magnitude of this discrepancy </plain></SENT>
</text></document>